Details for Patent: 9,636,344
✉ Email this page to a colleague
Which drugs does patent 9,636,344 protect, and when does it expire?
Patent 9,636,344 protects ALIQOPA and is included in one NDA.
This patent has fifty-three patent family members in forty-two countries.
Summary for Patent: 9,636,344
| Title: | Substituted 2,3-dihydroimidazo[1,2-C]quinazoline salts |
| Abstract: | The present invention relates to 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo-[1,2-- c]quinazolin-5-yl]pyrimidine-5-carboxamide dihydrochloride salt of formula (II): ##STR00001## or a tautomer, solvate or hydrate thereof; and to its use for the treatment of non-Hodgkin's lymphoma. |
| Inventor(s): | Peters; Jan-Georg (Solingen, DE), Militzer; Hans-Christian (Odenthal, DE), Muller; Hartwig (Velbert, DE) |
| Assignee: | Bayer Intellectual Property GmbH (Monheim, DE) |
| Application Number: | 14/990,350 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,636,344
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare | ALIQOPA | copanlisib dihydrochloride | POWDER;INTRAVENOUS | 209936-001 | Sep 14, 2017 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF ADULT PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR SYSTEMIC THERAPIES | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,636,344
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 11161111 | Apr 5, 2011 | |
International Family Members for US Patent 9,636,344
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 3709 | ⤷ Try a Trial | |||
| Argentina | 085718 | ⤷ Try a Trial | |||
| Australia | 2012238891 | ⤷ Try a Trial | |||
| Brazil | 112013025549 | ⤷ Try a Trial | |||
| Canada | 2832123 | ⤷ Try a Trial | |||
| Chile | 2013002870 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
